| Name | 5-oxoproline |
|---|---|
| Synonyms |
MFCD00064322
C5H7NO3 DL-Pyroglutamic acid -1 (+/-)-2-PYRROLIDINONE-5-CBOXYLIC ACID L-Pidolic acid DL-PYROGLUTAMIC ACID Ajidew A 100 (S)-(-)-γ-Butyrolactam-γ-carboxylic acid DL-5-Oxoproline dl-Pyrrolidone cboxylic acid (+/-)-2-PYRROLIDONE-5-CBOXYLIC ACID LABOTEST-BB LT00005913 DL-5-OXO-2-PYRROLIDINECBOXYLIC ACID 5-Oxopyrrolidine-2-carboxylic Acid DL-5-PYRROLIDONE-2-CBOXYLIC ACID H-DL-PYR-OH L-5-Oxoproline DL-Pyroglutamic acid (S)-(−)-Pyroglutamic acid DL-Pyroglutamic acid //BP DL-A-PYROGLUTAMIC ACID a-Aminoglutaric Acid Lactam DL- pyroglutaMate 5-oxo-proline (S)-(−)-2-Pyrrolidone-5-carboxylic acid DL-2-Pyrrolidone-5-cboxylic acid (-)-Pyroglutamic acid 5-Oxo-L-proline 5-Pyrrolidinone-2-carboxylic acid Pyroglutamic acid and esters PCA EINECS 205-748-3 (2S)-5-Hydroxy-3,4-dihydro-2H-pyrrole-2-carboxylic acid DL-Pyroglutamic acid, 10 mM in DMSO 2-Pyrrolidone-5-carboxylic acid (S)-(-)-g-Butyrolactam-g-carboxylic Acid (±)-2-Pyrrolidone-5-cboxylic acid, DL-5-Oxo-2-pyrrolidinecboxylic acid DL-Pyr-OH DL-Pyroglutamic H-DL-Pyr-OH DL-2-Pyrrolidone-5-carboxylic acid (S)-(-)-2-pyrrolidone-5-carboxylic acid Pyrrolidonecarboxylic acid D,l-2-pyrrolidone-5-cboxylic acid PyroGlu DL-PyroglutamicAcid> DL-GLUTAMIC ACID LACTAM DL-5-Oxo-2-pyrrolidinecboxylic acid, DL-Pyroglutamic acid (^+)-2-Pyrrolidinone-5-cboxylicacid Pyroglutamic acid DL-2-PYRROLIDINONE-5-CBOXYLIC ACID (n)-2-pyrrolidinone-5-cboxylic acid DL-2-Pyrrolidone-5-cboxylic acidCNA10145 L-Glutamic Acid g-Lactam Cboglutamate impurity 6 D,l-2-Pyrrolidone-5-Carboxylic Acid DL-Glutamic Acid Lactam 2-Pyrrolidone-5-cboxylic Acid DL- pGlu-OH 2-Pyrrolidone-5-cboxylic acid DL-Proline, 5-oxo DL-PYR 5-OXO-DL-PROLINE Glutamic Acid Lactam 2-L-Pyrrolidone-5-carboxylic acid pidolic acid DL-Glutamic Acid Lactam 5-L-oxoproline |
| Description | DL-Pyroglutamic acid (CAE) as an inactivator of hepatitis B surface, inactivates vaccinia virus, herpes simplex virus, and influenza virus except poliovirus. DL-Pyroglutamic acid is also a possible inhibitor of GABA transaminase, increases GABA amount with antiepileptic action[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | DL-Pyroglutamic acid results 50 and 100% inactivation of the antigen of 0.01-0.025% and 0.025-0.05%, respectively[1]. DL-Pyroglutamic acid is a possible glutamate antagonist, blocks glutamate miniature-end-plate potential in locust muscle-Druce and Bradford[2]. |
| In Vivo | DL-Pyroglutamic acid (0.775 mM/L) completely abolishes the myoclonic jerks and EEG spikes in rats model of epileptic by cobalt implantation in the sensorimotor cerebral cortex[2]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 453.1±38.0 °C at 760 mmHg |
| Melting Point | 180-185ºC |
| Molecular Formula | C5H7NO3 |
| Molecular Weight | 129.114 |
| Flash Point | 227.8±26.8 °C |
| Exact Mass | 129.042587 |
| PSA | 66.40000 |
| LogP | -2.39 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.512 |
| Water Solubility | 5.67 g/100 mL (20 ºC) |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 29337900 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2933790090 |
|---|---|
| Summary | 2933790090. other lactams. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:9.0%. General tariff:20.0% |